RENAISSANCE TECHNOLOGIES LLC

Position in SRZN — Surrozen, Inc./DE

CIK 1037389 NEW YORK, NY

Position in SRZN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,431,040

+$919,693 QoQ

Shares Held

49,126

+117.1% QoQ

Ownership

0.423%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 58 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,464,545,054 across 328 Biotechnology names. SRZN ranks #167 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,431,040	49,126	+117.1%	Shares	Sole	2026-05-14
2025-12-31	$511,347	22,626	+53.6%	Shares	Sole	2026-02-12
2025-09-30	$189,744	14,726	+0.7%	Shares	Sole	2025-11-13
2025-06-30	$130,756	14,626	+2.8%	Shares	Sole	2025-08-13
2025-03-31	$165,875	14,226	+5.2%	Shares	Sole	2025-05-14
2024-12-31	$194,098	13,526	-2.2%	Shares	Sole	2025-02-13
2024-09-30	$165,635	13,826	+11.3%	Shares	Sole	2024-11-13
2024-06-30	$136,064	12,426	-9.5%	Shares	Sole	2024-08-09
2024-03-31	$215,635	13,726	+32.9%	Shares	Sole	2024-05-13
2023-12-31	$97,064	10,326	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.